BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15731165)

  • 21. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
    López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
    BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma.
    Tomescu D; Kavanagh G; Ha T; Campbell H; Melton DW
    Carcinogenesis; 2001 Mar; 22(3):403-8. PubMed ID: 11238179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk.
    Khan SG; Metin A; Gozukara E; Inui H; Shahlavi T; Muniz-Medina V; Baker CC; Ueda T; Aiken JR; Schneider TD; Kraemer KH
    Hum Mol Genet; 2004 Feb; 13(3):343-52. PubMed ID: 14662655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
    Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland.
    Jorgensen TJ; Visvanathan K; Ruczinski I; Thuita L; Hoffman S; Helzlsouer KJ
    Breast Cancer Res Treat; 2007 Jan; 101(1):65-71. PubMed ID: 16823510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The xeroderma pigmentosum group C gene polymorphisms and genetic susceptibility of nasopharyngeal carcinoma.
    Yang ZH; Liang WB; Jia J; Wei YS; Zhou B; Zhang L
    Acta Oncol; 2008; 47(3):379-84. PubMed ID: 17882560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The XPC poly-AT polymorphism in non-melanoma skin cancer.
    Nelson HH; Christensen B; Karagas MR
    Cancer Lett; 2005 May; 222(2):205-9. PubMed ID: 15863269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
    Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
    Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism in the nuclear excision repair gene ERCC2/XPD: association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma.
    Lovatt T; Alldersea J; Lear JT; Hoban PR; Ramachandran S; Fryer AA; Smith AG; Strange RC
    Hum Mutat; 2005 Apr; 25(4):353-9. PubMed ID: 15776433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xeroderma pigmentosum group C in a French Caucasian patient with multiple melanoma and unusual long-term survival.
    Jacobelli S; Soufir N; Lacapere JJ; Regnier S; Bourillon A; Grandchamp B; Hétet G; Pham D; Palangie A; Avril MF; Dupin N; Sarasin A; Gorin I
    Br J Dermatol; 2008 Sep; 159(4):968-73. PubMed ID: 18717677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study.
    Millikan RC; Hummer A; Begg C; Player J; de Cotret AR; Winkel S; Mohrenweiser H; Thomas N; Armstrong B; Kricker A; Marrett LD; Gruber SB; Culver HA; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Busam K; From L; Mujumdar U; Berwick M
    Carcinogenesis; 2006 Mar; 27(3):610-8. PubMed ID: 16258177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients.
    Khan SG; Oh KS; Shahlavi T; Ueda T; Busch DB; Inui H; Emmert S; Imoto K; Muniz-Medina V; Baker CC; DiGiovanna JJ; Schmidt D; Khadavi A; Metin A; Gozukara E; Slor H; Sarasin A; Kraemer KH
    Carcinogenesis; 2006 Jan; 27(1):84-94. PubMed ID: 16081512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells.
    Takebe H; Nishigori C; Tatsumi K
    J Invest Dermatol; 1989 May; 92(5 Suppl):236S-238S. PubMed ID: 2715657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XPC polymorphisms and lung cancer risk.
    Lee GY; Jang JS; Lee SY; Jeon HS; Kim KM; Choi JE; Park JM; Chae MH; Lee WK; Kam S; Kim IS; Lee JT; Jung TH; Park JY
    Int J Cancer; 2005 Jul; 115(5):807-13. PubMed ID: 15729698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.
    Bradford PT; Goldstein AM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Pike KM; Raziuddin A; Plona TM; DiGiovanna JJ; Tucker MA; Kraemer KH
    J Med Genet; 2011 Mar; 48(3):168-76. PubMed ID: 21097776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
    Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
    Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.
    Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH
    J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
    Mandal RK; Gangwar R; Mandhani A; Mittal RD
    DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma.
    Oliveira C; Rinck-Junior JA; Lourenço GJ; Moraes AM; Lima CS
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1199-206. PubMed ID: 23568549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
    Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
    Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.